Fintech PR
How Payback Ltd Reimbursed Over $5,000,000 To Victims Of Financial Fraud in 2023
TEL-AVIV, Israel, Jan. 18, 2024 /PRNewswire/ — Payback Ltd is on a mission to save victims of fraud across the globe and recovered millions in stolen funds in 2023. The enormity of financial fraud worldwide in 2024 is staggering and almost impossible to calculate, but Payback Ltd will continue to help victims one case at a time throughout the year. In the first three quarters of 2023, Payback Ltd successfully recovered over $5,000,000 in lost funds and has no intention of taking its foot off the gas.
Payback Ltd is poised to build on its success in 2023, leveraging a multifaceted approach that targets not just the perpetrators but also the institutions complicit in these fraudulent activities. The process begins with the victim, who provides crucial information that becomes the foundation for Payback Ltd’s pursuit of justice.
Payback’s team of financial experts plays a pivotal role in securing the relevant information from the scam victim. This initial step is crucial, laying the groundwork for a meticulous and strategic recovery process. The organization’s recovery specialists and legal department, armed with years of collective knowledge and expertise, meticulously track down and confront those responsible.
“The Team at Payback does everything in our power to give every client the highest possible chance of success. This is why our screening process is so extensive, as we want everyone to win their case.” Said Amir Geva, Co-Founder of Payback Ltd
Engaging with Payback Ltd is not just a transaction; it is the initiation of a process that holds the promise of reclaiming what has been wrongfully taken. Victims are only a short conversation away from embarking on the journey to secure their stolen assets. This client-centric approach underscores Payback Ltd’s singular mission: to help people recover from frauds and scams worldwide, no matter the complexity or intricacy involved. The organization serves as a formidable force, equipped with wealth recovery experts, scam money recovery professionals, and fund recovery specialists who bring a wealth of experience to the table.
Payback Ltd operates on a very selective basis, so they only take on clients that they believe have the utmost chance of success and do everything in their power to make that happen. No two cases are the same, so every minute aspect of each case must be documented and scrutinized to achieve the highest chance of positive results.
Although there are never any guarantees when dealing with sophisticated criminality, Payback Ltd utilizes every resource in its arsenal, along with its decades of expertise in these matters to make sure its success rate stays second to none. With a team made of experts across every relevant industry, every client is guided and advised through the intricacies of their case. The process can take months, or even years, but is all the more worth it when a client is successful in recouping their funds. With each successful case, Payback Ltd reaffirms its commitment to dismantling the intricate web of financial fraud, one recovery at a time.
“We see the grim reality of these scams and the impact they have on people’s lives. I wouldn’t wish it on my worst enemy, but realistically, it happens more than any of us can imagine. We also understand that financial institutions have a duty of care to their clients, and many of them don’t do enough to help them get their money back. That’s where we come in.” Concluded Amir.
Payback Ltd has one wish – that no one falls victim to financial fraud. However, in the harsh reality of a world rife with scams, the organization stands as a hope for those who find themselves ensnared in the clutches of deception. The recovery process may be arduous, but Payback Ltd’s track record speaks volumes about its efficacy. Victims are not just reclaiming stolen assets; they are reclaiming a sense of control over their financial destinies. As 2024 goes on, Payback Ltd’s goal is to continue to help victims of financial fraud across the globe.
Media contact:
Name: Sam Woods
Email: [email protected]
Phone No: +972-3-3095410
View original content:https://www.prnewswire.co.uk/news-releases/how-payback-ltd-reimbursed-over-5-000-000-to-victims-of-financial-fraud-in-2023–302038680.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News3 days ago
Trina Storage Recognized as Tier 1 Energy Storage Manufacturer by BNEF for Second Consecutive Quarter
-
Latest News3 days ago
Bank of Spain grants Amadeus’ Outpayce EMI licence
-
Latest News3 days ago
Newmark Reports First Quarter 2024 Financial Results
-
Latest News3 days agoGenome and Chilli Partners join forces to revolutionize iGaming affiliate payouts
-
Latest News3 days ago
EQT to acquire WSO2, a leading global provider of digital transformation technologies
-
Latest News4 days ago
Lunar Poised for Nationwide Rollout in Sweden After Securing €24.1 Million in Funding
-
Latest News3 days ago
REALTY ONE GROUP CELEBRATES 19TH ANNIVERSARY WITH GLOBAL ‘ONE DAY’ OF VOLUNTEERING & GIVING BACK
-
Latest News3 days ago
BIZCLIK MEDIA LAUNCHES MAY EDITION OF FINTECH MAGAZINE
